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Abstract 62 
The classification and monitoring of individuals with early OA is an important strategy for the design and 63 
evaluation of therapeutic interventions. Such an approach requires the identification of appropriate 64 
outcomes measures. Potential outcome measures for early OA include patient-reported outcomes (such 65 
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as measures of pain, function or quality of life), features of clinical examination (such as joint line 66 
tenderness and crepitus (that is, grating and crackling  sounds)), objective measures of physical function, 67 
levels of physical activity, movement biomechanics, structural assessments such as magnetic resonance 68 
imaging (MRI) and body fluid biomarkers. Patient characteristics such as adiposity and biomechanics of 69 
the knee could also have  relevance to early OA. Importantly, future research is needed to enable the 70 
selection of outcome measures that are feasible, reliable, and validated in those at risk of OA and an early 71 
knee OA population. In this Perspectives paper, potential outcome measures of individuals with early 72 
symptomatic knee osteoarthritis (OA) are discussed, including those that could be of use in clinical practice 73 
as well as research settings. 74 
 75 
[H1] Introduction 76 
Osteoarthritis (OA) is a leading cause of chronic pain, disability, and health care utilization, with knee OA 77 
contributing the greatest burden1-4. OA is associated with increased rates of comorbidity (for example, 78 
obesity and heart disease)1 and ranks the 13th 2 most burdensome amongst all forms of disability world-79 
wide. The incidence and burden of OA is considerable and growing3, 5. Therefore, a shift in the treatment 80 
approach is needed from treating patients once they have established OA to a proactive approach that 81 
focuses on mitigating risk factors. The classification and monitoring of early OA, on a trajectory from 82 
normal to symptomatic and/or radiographic OA, would provide an opportunity in clinical practice and 83 
research for the development and evaluation of interventions to prevent or slow down the disease process 84 
at a time it is probably more amenable to modification.  85 
Although the definition of early OA and appropriate outcomes are under development OA is probably 86 
heterogeneous in terms of its presentation and progression. Knee OA might progress slowly over a period 87 
of ten or more years, rapidly, or not at all6. Predicting the development and progression of disease through 88 
identifying risk factors and mechanisms of OA is important in chronic disease management to inform 89 
targeted OA prevention and treatment strategies. This strategy is difficult because of the heterogeneous 90 
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presentation of OA; however, the availability of increasingly sophisticated statistical and computational 91 
methods, microsimulation modelling, and large population-based cohort studies make this approach 92 
increasingly viable. For example, widely-used online prediction tools are now available for evaluating 93 
future risk of osteoporotic fractures and for guiding clinicians in preventive management of osteoporosis7-94 
9. Comparable reliable and validated outcomes for early OA will inform the evaluation of risk factors for 95 
the progression of early OA. More than one set of risk factors and models will probably be needed to 96 
predict early OA in the future. The Rotterdam and Chingford studies (two prospective population-based 97 
studies) have demonstrated an ability to predict incident radiographic knee OA using a combination of 98 
clinical, genetic, and radiographic factors10. When performing risk assessment and creating a predictive 99 
model for early knee OA, many aspects need to be considered: the definitions of the outcome and 100 
prognostic factors; the duration of the clinically relevant prediction period; and the setting in which the 101 
risk prediction tool will be used (for example, primary care, secondary care or a research setting). For 102 
instance, expensive and intensive predictive tools such as MRI scans and biomarkers might be restricted 103 
to secondary care and/or a research setting. 104 
In this Perspectives article, we highlight considerations for best practice in the selection of outcome 105 
measures for use in clinical and research settings to evaluate patients at initial presentation of early knee 106 
OA across different outcome domains: patient-reported outcomes, clinical examination, physical function, 107 
adiposity, physical activity, nutrition, biomechanical outcomes, imaging features and biochemical markers 108 
11. We suggest outcome measures that could be considered for use in individuals with early knee OA in 109 
clinical care and research settings using published evidence (primarily from post-traumatic and established 110 
OA populations), emerging evidence (ongoing studies), and clinical expertise (Box 1). The outcome 111 
measures highlighted are relevant to individuals that are at risk of OA and fit the provisional criteria for 112 
early knee OA based on patient reported outcomes of pain and function, together with clinical signs (joint 113 
line tenderness or crepitus) and a radiographic Kellgren-Lawrence (KL) grade of 0-112. Although proposed 114 
as important evidence-informed clinical outcome measures, these outcome measures will require 115 
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additional validation and possible modification to suit local primary care and other healthcare settings, as 116 
well as periodical updates. 117 
 118 
Patient-reported outcomes 119 
Patient-reported outcomes are any report of a patient’s health status that comes directly from the patient 120 
without interpretation by others (for example, the clinician). These measures commonly take the form of 121 
a questionnaire. Most relevant patient-reported outcome measures have been developed to either assess 122 
individuals with a knee injury (for example, International Knee Documentation Committee 2000 123 
(IKDC2000)) or established OA (for example, Western Ontario and McMaster Osteoarthritis Index 124 
(WOMAC)); although, one questionnaire has been developed to cover the full spectrum from injury to 125 
established OA (the Knee Injury and Osteoarthritis Outcome Score (KOOS)). The relative merits of these 126 
and other available instruments that measure self-reported pain, function, and quality of life have been 127 
the subject of previous reviews13, 14. Today measures, such as PROMIS, are often developed using 128 
computer adaptive strategies which may also prove to be relevant for use in people with early OA15. Many 129 
of the considerations that influence the choice of measure in established OA (for example, respondent 130 
burden, cost or availability) apply also in early OA.  131 
Ultra-brief (one or two domains) unidimensional generic measures, such as the 11-point Numerical Rating 132 
Scale (NRS-11), the 36-Item short form health survey (SF-36)  bodily pain scale (SF-BP 36), have been 133 
recommended in previous reviews for established OA16 and are probably applicable also in early OA. 134 
However, the disadvantage of generic health status measures is a restricted view of the pain character and 135 
intensity16, 17, which is probably inappropriate based on emerging evidence from qualitative studies in 136 
patients with early knee OA18-20. For instance, these patients report that their initial symptoms can be 137 
experienced as ‘an awareness’ of the knee, loss of confidence, or needing to ‘be careful’ as opposed to 138 
‘pain’. The KOOS knee-related quality of life subscale includes consideration of questions on these aspects 139 
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14,15. Further, reporting OA pain as ‘constant’ or ‘present on most days’ might give floor effects (i.e., most 140 
individuals may report at the lower end of the scale) in early OA as these patients often report episodic 141 
and intermittent pain with certain activities. For example, pain during ascending or descending stairs 142 
seemed to be the earliest functional difficulty reported in the OA initiative21. Accordingly, the intermittent 143 
and constant assessment of pain score (ICOAP) questionnaire, which includes a subscale on intermittent 144 
symptoms, has an increasing amount of evidence supporting its’ reliability and validity.22. 145 
Another important consideration is that the early phase of knee OA is often associated with the emergence 146 
of adaptive behaviour. Symptom frequency and intensity might be minimized through the selection of 147 
behaviours (for example, performing some activities less often), optimization of behaviours (for example, 148 
advanced planning of activities, including anticipatory analgesic use), and compensatory adaptations (for 149 
example, modifying the way activities are performed)23. Therefore, consideration of adaptive behaviour is 150 
a legitimate topic for outcome measurement in early OA24, an example of which is the Questionnaire to 151 
Identify Knee Symptoms (QuIKS). QuIKS includes questions such as “I am considering stopping a favorite 152 
activity due to my knees” and “I am considering changing my exercise routine due to my knee problems”25  153 
The KOOS was developed for self-reporting of patient-relevant outcomes across the lifespan, from time of 154 
knee injury and potential knee OA onset to severe OA26-29. In five separate subscales this tool assesses 155 
perceived pain and other symptoms (e.g., stiffness, grinding, catching), perceived difficulty with function 156 
during daily life and sport and recreational activities, and knee-related quality of life. The KOOS 157 
measurement properties have been reported in studies of young, middle-aged, and elderly groups with 158 
knee injury or OA, and across the spectrum of treatments14. A comprehensive literature search identified 159 
37 eligible papers evaluating KOOS measurement properties in participants with knee injuries and/or 160 
osteoarthritis (OA) and found that KOOS demonstrates adequate content validity, internal consistency, 161 
test-retest reliability, construct validity and responsiveness for age- and condition-relevant subscales14.The 162 
KOOS is feasible to administer electronically and in paper form and KOOS scoring instructions and 163 
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population-based KOOS reference data are available. In addition, longitudinal KOOS data have been 164 
collected from more than 100,000 patients in surgical registries of anterior cruciate ligament 165 
reconstruction and knee replacement facilitating comparisons to many different populations30, 31. In 166 
addition, for the interested researcher, KOOS data are freely available and collected from the cohort of 167 
patients who are at increased risk of OA and the cohort of patients with established disease from the NIH-168 
sponsored OA Initiative32. The OA initiative also collects a wide range of other self-reported, clinical and 169 
imaging data32. The “at risk “ cohort includes people with symptoms and two or more risk factors (including 170 
knee injury) but without radiographic OA32. 171 
The ICOAP was designed to evaluate the pain experience in people with OA. It includes pain intensity, 172 
frequency, and impact on mood, sleep and quality of life. It is intended to be used alongside a measure of 173 
physical function22. OA-specific measures developed for more advanced OA cannot be assumed to have 174 
adequate psychometric properties when applied to early OA. Yet, the requirement for adequate 175 
performance in early OA must be balanced against the benefits for a coherent evidence base that comes 176 
from using common measures across the spectrum from early to advanced OA. Of existing measures, the 177 
KOOS and ICOAP seem to best strike this balance and are therefore strong candidates for evaluating early 178 
knee OA (Box 1), particularly as these instruments focus on different aspects; both have the advantage of 179 
being freely available. Published reviews of the psychometric properties of these two measures require 180 
systematic updating with specific attention to their performance in early OA.  181 
 182 
Clinical examination outcomes 183 
Clinical examination outcomes are relevant in research and are easy to  perform in primary care. Joint line 184 
tenderness (tibiofemoral and/or patellofemoral joint lines) at baseline was suggested to be a strong 185 
predictor of five-year pain progression (moderate progression adjusted OR=3.9 (95% CI; 2.3 - 6.6)33 in the 186 
CHECK cohort (n=705) that included patients with newly onset knee pain or stiffness34. Several studies 187 
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have evaluated the ability of physical signs to predict the clinical onset of structural radiographic OA in 188 
patients with an increased risk of OA 33-37. Data from the HONEUR Study, which included 549 participants 189 
who were recruited at the first presentation of knee pain in primary care, suggested that joint line 190 
tenderness, crepitus (that is, grating, crackling, popping sounds), pain with passive flexion, and a self-191 
reported swollen knee predicted incident radiographic tibiofemoral knee OA after 6 years35. Using MRI 192 
features of knee OA as an outcome measure, data from the  general population Rotterdam Study showed 193 
that joint line tenderness together with the ‘feeling of giving way’ were associated with the incidence of 194 
tibiofemoral knee OA, whereas crepitus was identified as a good predictor of patellofemoral OA36, 37.  195 
 Easily assessable measures from physical examination might be associated with future OA development, 196 
including joint line tenderness and crepitus, even in the absence of radiologic findings of OA (Box 1). 197 
Clinical examination of these features had good inter-observer reliability in a population with evident knee 198 
osteoarthritis if a standardised approach to such assessment is used38. However, these clinical assessment 199 
components require further examination of reliability and validation for research settings in early knee OA 200 
and standardization for use in clinical settings. 201 
Physical function outcomes 202 
Given that the early pre-radiographic stage of OA is associated with intermittent symptoms and adaptive 203 
physical behaviour, the clinical evaluation of patients with, or at risk of, early knee OA should incorporate 204 
robust outcome measures of physical function39. Currently, no consensus exists regarding which outcomes 205 
are most relevant for use in this population. For the purposes of this Perspective article, physical function 206 
is operationally defined as ‘physiological functions’ or ‘the ability to move around and to perform daily 207 
activities’ that can be classified as ‘body functions and structure’ or ‘activities and participation’, 208 
respectively, using the World Health Organization International Classification of Functioning, Disability and 209 
Health (ICF) model40. As physical function is multi-dimensional, both performance-based and physical 210 
impairment measures (which might require specialized pieces of equipment and raters) are discussed in 211 
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this section. Emerging evidence suggest that some of these outcome measures might be suitable for the 212 
evaluation of early OA and those at risk of OA (Table 1)41-46.  213 
A range of performance-based measures are available although the degree to which their measurement properties 214 
are established and the range of populations they have been used in varies (Table 1). Measures that have 215 
undergone fairly extensive investigation include the Single Leg Hop for distance test43, 44, 47-50, the Cross Hop for 216 
distance43, 47-50, the 6-meter Timed Hop Test43, 47-50, the Star Excursion  and similar Y-balance test44, 51-55, the 30-217 
second Chair Sit-to-Stand Test56-58, and the 6-minute walk test41, 42, while there is emerging evidence for the Vertical 218 
Drop Jump 44, 59, the Single Leg Squat 44, 60-62, Unipedal Dynamic Balance test 44, 63 and 20-meter Shuttle Run44, 64. The 219 
most commonly reported outcome of physical impairment is quadriceps muscle strength44, 47, 48, 51, 65, however, 220 
there might also be value in considering the strength of other lower extremity muscles including the hamstring, hip 221 
abductor and hip adductor muscle.; although, insufficient information is available to advocate for specific 222 
contraction mode (i.e., isotonic, isokinetic or isometric) or type (i.e., concentric or eccentric). 223 
Because of floor and ceiling effects (i.e., most individuals report a minimum – floor, or maximum – ceiling 224 
score), separate measures are required to cover the wide range of ages and abilities of patients with early 225 
knee OA in both clinical and research settings. Functional outcomes that should be considered for use in 226 
research and in clinical physical and exercise therapy practice based on their measurement properties and 227 
ability to span the full spectrum of patient age and abilities include the Single Leg Hop for distance, 30-228 
second Chair Sit-to-Stand Test, 6-minute walk test and a quadriceps strength measure. The performance-229 
based outcomes should be administered in a standardized, validated and reproducible fashion to enable 230 
detection of change over time; video demonstrations and explicit instructions for standardized testing are 231 
available online (see related links). Further research validating functional outcomes in ‘at risk’ (e.g., intra-232 
articular knee injury, obesity, varus/valgus alignment abnormality) and ‘early-OA’ populations is required 233 
and this research should inform the periodic updating of these suggested functional outcomes. 234 
 235 
Modifiable lifestyle-related outcomes 236 
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The presence of modifiable risk factors related to lifestyle, such as obesity, dietary inadequacies, and 237 
physical inactivity might lead to accelerated disease onset and progression through a combination of 238 
mechanical and systemic mechanisms66. Identifying these modifiable risk factors in early knee OA is 239 
important for the prevention of OA.  240 
Several measures of adiposity or weight have been studied in established OA, but less so in early OA. These 241 
include BMI, waist-height ratio (WHR) and waist circumference67-71. The location of fat depots influences 242 
their metabolic and inflammatory potential and therefore may be important considerations. A high waist-243 
height ratio or waist circumference (indicative of abdominal adiposity) were associated with an increased 244 
risk of OA progression71; however, neither outcome was associated with the loss of tibial or patellar 245 
cartilage volume or defects in adults in the community with pre-radiographic OA72, 73. To detect a change 246 
in visceral fat at this early stage, more accurate assessments of abdominal adiposity are needed. 247 
Measurements of fat mass (kg), percentage fat mass (percentage of total mass) and fat mass index (FMI; 248 
fat mass/height2), can be obtained using dual-energy x-ray absorptiometry or bioelectrical impedance 249 
analysis, hence permitting a direct measure of adiposity74. Total fat mass is positively associated with an 250 
increased risk of knee cartilage defects and the presence of bone marrow lesions in healthy individuals 251 
(aged 25-60 years)75 and medial tibiofemoral cartilage volume loss over 2-10 years in adults aged 51-81 252 
years76, 77. A systematic review reported moderate evidence for the relationship between obesity (that is, 253 
increasing weight, BMI or total body fat mass) and the presence of bone marrow lesions in the knee in 254 
individuals with OA70. In addition to contributing to an increased mechanical load, adiposity is thought to 255 
have a metabolic and pro-inflammatory function in OA; therefore, a direct measure of adiposity (fat mass, 256 
percentage fat mass or FMI) rather than BMI, might be more useful in the assessment of early-stage OA78-257 
81. 258 
Physical activity is a modifiable outcome that might delay the onset of functional limitation, prevent 259 
obesity, and is essential for normal joint health82. In addition, physical activity can reduce pain and 260 
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disability among individuals with OA and increase their physical performance and self-efficacy83-85. Light or 261 
moderate intensity physical activity might protect against the onset of disability related to symptomatic 262 
OA, whereas a sedentary lifestyle or levels of strenuous physical activity is considered a risk factor86-88. 263 
Many variations of self-reported measures of physical activity exist including global or short recall 264 
questionnaires, although most have limited accuracy86-88. Wearable monitors that measure body motion 265 
can be used to assess physical activity and energy expenditure. The most commonly used sensor, validated 266 
across multiple populations, is an accelerometer (for example, Actigraph)89, which captures frequency, 267 
intensity, and duration of physical activity in a time-stamped manner. The large selection of off-the-shelf 268 
accelerometers, often contained in mobile phones, might be more suitable in a primary care setting to 269 
measure physical activity as they are less expensive, easier to use and widely available90, 91. Most 270 
accelerometers, however, are not validated to measure cycling or swimming. In general, objective 271 
measures of physical activity such as accelerometer outcomes compared with self-reporting have stronger 272 
relationships with function in OA92 and are a more accurate assessment of physical activity and sedentary 273 
lifestyle.  274 
Nutrition interventions such as weight loss93, 94 are lifestyle-related changes that can potentially improve 275 
OA symptoms. Beyond the link between obesity and knee OA (and therefore the important contribution 276 
of weight loss)95, 96, the contribution of nutritional factors is an emerging and important area of research, 277 
although limited clinical evidence is available to date. For example, low dietary intakes of fibre97 or omega-278 
3 polyunsaturated fatty acids98, and high fat diets99 are risk factors for OA and/or worsening of pain in OA 279 
and might therefore warrant monitoring in early OA. Many of the nutrients or dietary patterns tested to 280 
date probably contribute to pathology via alterations in body weight or inflammation, although the direct 281 
effects of these factors requires further investigation. The tools to monitor dietary intake are numerous 282 
(for example, the Food Frequency Questionnaire (FFQ), 24-hour dietary recall (either the paper-based or 283 
web-based automated self-administered 24-hour dietary recall (ASA24) assessment tools100) and the 3-284 
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day or 7-day weighed food record) and need to be assessed for each clinical or research setting. In addition, 285 
tools to assess adherence to diets that reduce inflammation such as the Mediterranean Diet Adherence 286 
Screener101 might also warrant use in future.  287 
Hence, objective measures of adiposity are desirable. BMI is a useful outcome measure for assessing 288 
adiposity in a primary clinical setting because of its familiarity, validity, and reference ranges. However, 289 
BMI has limitations for use in young athletes. Although weight loss can improve OA symptoms, further 290 
research is needed to identify a means of assessing important OA-related nutritional factors. Assessment 291 
of physical activity using a validated accelerometer, to accurately capture activity through each domain 292 
and intensity, is a promising area that requires future study.  293 
 294 
Biomechanical outcomes 295 
Biomechanical outcomes are measures of joint mechanics typically collected in a research setting, but 296 
sometimes taken in a primary care setting. Joint mechanics can be employed to assess OA severity, but 297 
also for understanding the causes of OA onset and progression. For example, altered joint mechanics 298 
following knee injury might contribute to the onset and development of post-traumatic OA39. Indirect 299 
evidence to support this concept comes from observations of altered joint movement, loading, and muscle 300 
activation patterns following injury102-107, with radiographic knee OA (KL≥2)108-110, with aging111, 112 and pre 301 
and post joint arthroplasty113-115. Abnormal joint alignment116, 117, alteration of the external knee adduction 302 
moment (KAM) and increased varus alignment are often regarded as indicators of altered joint mechanics 303 
associated with increased OA severity110. However, joint mechanics in OA might also change because of 304 
other factors including loss of dynamic joint stability118, 119, muscle atrophy120, neuromuscular inhibition121, 305 
muscle weakness,122-124 and compensatory muscle activation mechanisms108, 109, 114. These changes might 306 
alter cartilage loading and contact mechanics. Indeed, some studies indicate changes in tibiofemoral 307 
cartilage contact locations39, 125, elongated path lengths126, force magnitudes103, 127, 128, and deformations125, 308 
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126 are associated with OA onset and progression. In turn, OA progression might be caused by progressive 309 
degradation of cartilage through interactions of articular movement and cartilage loading abnormalities, 310 
chronic inflammation, resultant tissue remodelling, and other OA risk factors by increasing the 311 
susceptibility of cartilage and subchondral bone to damage and degradation at regions inadequately 312 
adapted to these altered loads125, 129-133. Over time, this process might result in altered cartilage thicknesses 313 
and clinically relevant cartilage thinning in different regions of the articular cartilage surfaces. To verify 314 
this mechanism, longitudinal data are needed of the joint mechanics, cartilage thickness, and cartilage 315 
structure and integrity in OA134, 135. Integration of this information with other risk factors for OA-related 316 
changes might inform the development of novel patient-specific, diagnostic or predictive models to aid in 317 
early patient screening, intervention efficacy monitoring, and the development of new therapeutics127, 128, 318 
130, 136, 137. Armed with these data and models, new wearable monitors might enable biomechanical 319 
outcomes assessment in the clinic and community131-133, 138, 139, and might provide the possibility of 320 
developing and monitoring personalized treatment plans.  321 
Presently, the joint range of motion is a suggested measure that could be collected in a primary care setting 322 
to assess OA severity.  The other biomechanical outcomes mentioned above (e.g., KAM, kinematics, 323 
electromyography, cartilage loading) although  used to understand the mechanisms of OA progression  324 
and currently not feasibly collected in most clinical settings, are an important component for consideration 325 
in research settings to inform orthotics design, exercise interventions, bracing, and surgical interventions. 326 
In the future, validated wearable monitors might help assess biomechanical outcomes of early 327 
interventions in the clinic and community. Evidence suggests that outcome measures are not independent 328 
but rather variation in one outcome measure (for example, biomechanical outcomes) can influence the 329 
quantitative state of another measure (for example, biomarkers or imaging outcomes)140-144. Thus, future 330 
research should consider the interaction between different outcome measures to potentially increase the 331 




Imaging outcomes 334 
Osteoarthritis is a complex syndrome that at the local level, is best characterised as a whole joint disease 335 
involving multiple tissue pathologies. In attempting to characterise and monitor the variety of OA 336 
structural components a number of different imaging modalities have been used-the most common 337 
amongst these being x-ray, ultrasound and MRI. This section will predominantly focus on plain 338 
radiography and MRI, as ultrasound has a number of limitations that have constrained its development 339 
and validity in this area including observer dependency and an inability to adequately image weight-340 
bearing portions of the joint. 341 
Radiographic features of OA are generally classified by the Kellgren and Lawrence (KL) grading system145 342 
and include joint space narrowing, osteophyte formation, sclerosis, and deformity of bony contours146. 343 
Minimum radiographic joint space width (JSW) is the gold standard recommended by the FDA for detecting 344 
structural changes in patients with knee OA in clinical trials. Standardized measures of radiographic 345 
positioning and fixed location JSW can reach the same degree of responsiveness as quantitative measures 346 
of cartilage thickness on MRI 147. However, radiographic features such as loss of joint space, sclerosis, and 347 
deformity of bone are associated with late-stage OA and are preceded and detected with greater 348 
sensitivity by MRI.  349 
Conventional MRI enables the evaluation of morphological changes related to early OA, including but not 350 
limited to cartilage damage, meniscal damage, synovitis, presence of BMLs, and ligamentous damage. In 351 
one study of patients with knee pain (n=255, age 40-79 years), BMLs were present in 11% of individuals 352 
without radiographic OA (KL = 0), 38% of individuals with pre-radiographic OA (KL = 1) and 71% of 353 
individuals with radiographic OA (KL >2)148, 149. Similarly, 42% of patients with a diagnosis of symptomatic 354 
OA without radiographic features (KL < 2) had BMLs and 57% had cartilage loss150. Although a paucity of 355 
data exists regarding the timeline of structural changes in the period between a joint injury sustained in 356 
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youth and the onset of clinical post-traumatic OA, advanced MRI techniques have been used to detect 357 
subtle cartilage damage at the time of ACL injury151. Furthermore, macroscopic cartilaginous changes, the 358 
presence of BMLs, and bone morpholology changes might be detectable by conventional MRI techniques 359 
as early as two years post ACL reconstruction or other intra-articular knee injury (and potentially before 360 
the development of radiographic OA)6, 152-155.  361 
In 2011, a definition of MRI-defined OA was proposed to facilitate earlier detection of OA (Box 2)156, 157. In 362 
one study of patients who had undergone anterior cruciate ligament (ACL) reconstruction, 19% and 17% 363 
of the participants met the MRI criteria for tibiofemoral and patellofemoral OA, respectively, at 1 year158. 364 
Importantly, some of the changes included in this criteria are undetectable by radiography (i.e. cartilage 365 
thickness, bone marrow lesions). Different methodologies can be used to measure structural changes in 366 
the knee by MRI including the use of semi-quantitative measures (such as the MRI Osteoarthritis Knee 367 
Score (MOAKS)), quantitative measures (including cartilage thickness, bone marrow lesion volume, 368 
effusion-synovitis volume and meniscal extrusion) and measures obtained using compositional imaging 369 
modalities of cartilage (including T2 mapping, T1ρ mapping, delayed gadolinium-enhanced MRI of cartilage 370 
(dGEMRIC), sodium MRI and glycosaminoglycan chemical exchange saturation transfer (gagCEST)) which 371 
measure cartilage composition and quality159. Semiquantitative MRI evaluation can be performed using 372 
several available scoring systems such as the MRI Osteoarthritis Knee Score (MOAKS) and the Anterior 373 
Cruciate Ligament Osteoarthritis Score (ACLOAS)148, 160. For synovitis assessment, contrast-enhanced MRI 374 
should be used and semi-quantitative scoring systems based on contrast-enhanced MRI are available to 375 
enable clear delineation of the synovium from effusion161. In  population-based studies, a high proportion 376 
of radiographically normal knees have osteophytes and cartilage damage detectable by MRI illustrating 377 
the greater sensitivity of MRI as compared to radiography149. However, it also highlights the challenge of 378 
what is to be regarded as osteoarthritic disease and what is part of a normally ageing joint162. The link 379 
between anatomical evidence of OA and patients’ symptoms and function is still rather weak163, 164. 380 
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Ultimately, the presence of these findings on MRI require validation by longitudinal follow-up studies to 381 
identify their association with subsequent illness related to OA (alteration of patient function and 382 
symptoms)165 to avoid over-diagnosis because of incidental MRI findings148, 149, 166-168. Notably, the 383 
distinction between pathology and normal features of the ageing joint is unclear and further research to 384 
elucidate the importance of MRI findings in early knee OA is warranted. 385 
Hence, the utility of plain radiography in early OA is limited as only relatively late OA changes are 386 
detectable. As technology improves, assessing changes in bone shape or trabecular bone texture of sub-387 
chondral bone might be of use. MRI has superior sensitivity to change and validity in the context of early 388 
OA. Although not appropriate for all primary care settings because of the high cost and risk of over-389 
diagnosis, MRI is a critical component of ongoing outcome validation research in early knee OA. 390 
 391 
Biomarker outcomes 392 
Some laboratory OA biomarkers detectable in blood, urine or synovial fluid are associated with or 393 
predictive of incident radiographic knee OA. Biomarkers of joint tissue turnover can reflect disease-394 
relevant biological activity that might not otherwise be apparent before structural changes are detectable 395 
by MRI or plain radiography. Ideally, biomarkers of early OA must clearly differentiate between normal 396 
(physiological) and pathological tissue turnover as well as between the early stages of the disease and 397 
more advanced joint destruction. The biomarkers must also be unaffected by other disorders and be easily 398 
measured in a clinical setting169. Biomarkers of early OA might also be used to identify pre-radiographic 399 
changes at the molecular level and facilitate OA drug discovery, and potentially enable a more rational and 400 
personalized approach to healthcare OA management by prompting earlier and more targeted treatment 401 
170.  402 
Studies of incident OA have identified some of the earliest molecular abnormalities associated with OA 403 
and therefore provide biomarker candidates for early OA identification. 10 years prior to radiographic 404 
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hand or knee OA, four serum proteins (matrix metalloproteinase-7, IL-15, plasminogen activator 405 
inhibitor-1 and soluble vascular adhesion protein-1) were altered in a cohort of patients with OA 406 
compared with healthy individuals171. Similarly, serum COMP (sCOMP) and hyaluronan concentrations 407 
could predict172 incident knee joint space narrowing and osteophyte (sCOMP) formation 7 years later in 408 
another patient cohort. In another study, incident radiographic knee OA over ten years was positively 409 
predicted by serum COMP concentration (based on KL scores) at baseline but negatively predicted by 410 
serum aggrecan concentration173. Furthermore, mean baseline serum osteocalcin concentrations levels  411 
are associated with 3-year incident radiographic hand OA (KL >2) but not knee OA in pre-menopausal 412 
and peri-menopausal women174. Bioactive lipids are also potential biomarkers of pain and inflammation 413 
175 and metabolomics has been used to identify metabolic profiles that can differentiate between 414 
synovium samples from patients with OA and healthy individuals176.  415 
In 2006, the NIH-funded OA Biomarkers Network and the OARSI Clinical Trials Biomarkers Working group 416 
proposed a new classification system for OA biomarkers termed BIPEDS177, 178. The purpose of this 417 
classification was to clarify the intended primary use of the biomarker to reflect Burden of OA disease, 418 
Investigative, Prognostic for OA development, Efficacy of OA intervention, Diagnostic for OA and Safety of 419 
intervention biomarkers) classification system for OA biomarkers172,173. However, a systematic review 420 
performed in 2010 concluded that individual biochemical markers and categories of biochemical markers, 421 
including their nature, origin and metabolism, need further investigation and validation179. In 2016, the 422 
FDA-NIH Biomarker Working Group proposed the development of the BEST (Biomarkers, EndpointS, and 423 
other Tools) resource180. The BEST resource is a glossary that aims to distinguish between biomarkers and 424 
clinical assessments and to describe the distinct functions of biomarkers in biomedical research, clinical 425 
practice, and medical product development. BEST can be used to test, validate, and commercialize a 426 
biomarker to be used in clinical drug testing trials, and might also be used for improving biomarker 427 
development for early OA.   428 
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The profiling of biological fluids (for example, serum and synovial fluid) and joint tissues can provide a 429 
global view of the physiologic state of an OA joint. Refinements in omics approaches and advances in 430 
analytical techniques will enable improved profiling of different stages of disease. To be clinically useful 431 
these biomarkers need to be properly qualified (that is, a process needs to link a biomarker with other 432 
biological, biomechanical and clinical outcomes) for early OA and they must adhere to the BEST guidelines 433 
to be effectively used in a clinical setting, rather than in an exploratory and research setting. 434 
Soluble biomarkers require further study, validation, and qualification as susceptibility or risk outcomes 435 
for the development of early OA before being adopted for widespread use in the clinical care setting. Their 436 
contextualized evaluation in all OA research studies is encouraged. 437 
 438 
Conclusions  439 
 Various outcome domains exist that could be assessed for patients with early knee OA in research and/or 440 
clinical settings, including patient-reported outcomes, clinical features, measures of physical function, 441 
adiposity, physical activity or nutrition and biomechanical, imaging, or biochemical markers. Promising 442 
patient reported outcomes for this purpose include the KOOS and the ICOAP. Measures of physical 443 
outcomes (for example, single leg hop, quadriceps strength) and fat mass index (DXA) are also valid and 444 
reliable. With increasing popularity worldwide, a validated wearable physical activity monitor for 445 
quantifying levels of physical activity and a 3-day weighed food record for nutritional intake (for example, 446 
calories) has potential. MRI-defined OA and biomarkers, although promising, require specific healthcare 447 
and research settings where these outcomes are possible to collect. Additional considerations of patient-448 
preferences and psychosocial outcomes are also important in future research examining early knee OA 449 
outcome measures181. In this regard, further patient-engaged research is recommended. 450 
Importantly, multiple factors must be considered to facilitate risk assessment and the development of 451 
predictive models for early knee OA. Furthermore, definitions are needed for the potential outcomes, 452 
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exposures, confounding and effect-modifying variables, duration of the clinically relevant prediction 453 
period and the setting in which the risk prediction tool will be used. As such, further research validating 454 
outcomes in individuals ‘at risk’ of early OA progression (for example, individuals with an intra-articular 455 
knee injury and/or who are obese) and ‘early-OA’ populations is required. 456 
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Box 1. Proposed outcomes for the assessment of early pre-radiographic OA 
Below we provide suggestions for outcomes measures that could be used to assess individuals with early pre-
radiographic OA in clinical practice and in research settings. Further research is needed, including evaluation 
of validity of early-OA specific outcomes and change in outcomes with progression of OA as many of these 
measures have been evaluated primarily in established OA. 
In clinical practice and research settings: 
Patient-reported outcomes 
The Knee Injury and Osteoarthritis Outcome Score (KOOS) can be used to measure pain during activity, other 
symptoms (e.g., stiffness, grinding, catching, swelling, knee flexion and extension) , function in daily life and 
during sport and recreational activities, and quality of life across different age and treatment groups. The 
intermittent and constant assessment of pain score (ICOAP) can evaluate constant and intermittent pain. 
Clinical examination 
A clinical assessment including joint line tenderness should be performed on individuals with newly-onset 
symptoms of knee pain, stiffness, crepitus, or a feeling of ‘giving way’. 
Functional outcomes 
Three measures seem promising for use in clinical settings on the basis of their reproducibility, patient 
acceptability and the equipment and expertise required: Single leg hop test, 30 second chair sit-to-stand and 
quadriceps strength measure. Multiple additional functional measures have been validated for use in 
research settings. 
Lifestyle-related outcomes 
Adiposity can be assessed by body fat percentage or fat mass index (fat mass/height2) using dual-energy x-
ray absorptiometry or bioelectrical impedance analysis if available. BMI is more feasible in clinical settings, 
although has limitations for use in athletes. Levels of physical activity can be assessed using a validated 
physical activity monitor or a validated questionnaire if objective methods are not available. Nutrition 
outcomes are not currently suggested for use in routine clinical care, however the 3-day dietary record 
provides reliable estimates of nutrient intake. 
In research settings only: 
Biomechanical outcomes 
Measures of biomechanical outcomes require further research and are not currently suggested for use in 
routine clinical care. However, such outcomes are ideal for informing the underlying mechanisms of OA 
progression and informing treatment interventions in research setting. 
Imaging outcomes 
The utility of plain radiography in early OA is limited. Although MRI has superior sensitivity to change and 
validity in the context of early OA, and is hence ideal in research settings, MRI is not thought appropriate for 
the routine clinical care setting because of the high cost and potential risk of over-diagnosis. 
Biomarkers 
No biomarkers are currently of use in routine clinical care; however, further validation of proteomic, 
lipidomic and metabolomic tools in research settings could lead to informative cartilage and synovial fluid 
profiles and provide important insights into OA progression. 


















risk group (age) 
References 






Single leg hop 
for distance  
Length (cm) Measuring tape + - - - - +/- - Post-trauma 
(≤45 years)  
43, 44, 47-50 
Cross hop for 
distance 
Length (cm) Measuring tape + - - - - +/- - Post-trauma 
(≤45 years) 
40,44-4 
6 meter timed 
hop test 








measuring tape and 
skilled rater (leg 
length) 
+ + + + - +/- - Post-trauma or 





Count Chair and timer + + - - - - - Post-trauma or 
obese (all ages) 
53-55 
6 minute walk 
test 
Length (m) Flat 20m walking area, 
timer and chair 
- - - - - - - Obese (all ages) 41, 42 
Vertical drop 
jump 





Risk rating None + + - - +/- +/- - Post-trauma or 





Time (sec) Balance pad and timer - + + - + + - Post-trauma or 




Stage Coloured tape and 
instructions.  
- - + + -/+ + - Post-trauma 










+  + +  +  + + + Post-trauma or 
obese (all ages) 









+ + + + +/- +/- +/- Post-trauma or 























+ + + + - +/- - Post-trauma or 






Box 2 MRI-defined osteoarthritis92 
  
Tibio-femoral MRI-defined osteoarthritis (OA) is based on identifying the following MRI features in the 
medial or lateral tibio-femoral compartment: 
 
 Definite osteophyte AND full thickness cartilage loss 
Or 
 
 Definite osteophyte OR full thickness cartilage loss AND at least two of the following: 
 Sub-chondral bone marrow lesion not associated with meniscal or ligamentous attachment. 
 Meniscal subluxation (for example, meniscal extrusion), maceration or degeneration 
(including horizontal tear). 
 Partial thickness cartilage loss where full-thickness loss was not present. 
 Bone attrition in one of the tibiofemoral (medial or lateral) or patellofemoral joint 
compartments respectively.  
 
Mixed Tibio-femoral MRI-defined OA is based on meeting some of the above features in one 
compartment and others in a second compartment. 
 
Patellofemoral MRI-defined OA is based on identifying a definite osteophyte and partial or full-thickness 
cartilage loss in the patellofemoral compartment 
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